Both clinics offer BPC-157 and peptides. Marek Health wins on lab diagnostics and protocol depth. Limitless Alt Med wins on pricing transparency, free consultations, and accessible entry — with oral TRT and published per-compound pricing.
| Marek Health | Limitless Alt Med | |
|---|---|---|
| BPC-157 | Yes | $325 injectable |
| CJC-1295 / Ipamorelin | Yes | Not offered |
| PT-141 | $184 | $184 |
| Sermorelin | Yes | $194 |
| GHK-Cu | Yes | Yes — blends |
| TB-4 (Thymosin Beta-4) | Yes | Not offered |
| TRT | Full panel: TRT, HCG, Anastrozole, Enclomiphene | $115–$170/mo, oral + injectable |
| NAD+ | Yes | $180/vial (published) |
| GLP-1 | Yes | Sema sublingual $200, Tirze $275–$400 |
| Labs | Marek Diagnostics — 80+ biomarkers, $595 comprehensive | ~$150/yr TRT monitoring (recommended 4x/yr) |
| Consultation Fee | $250 | Free |
| Pricing Transparency | Pay-per-service (variable) | Published per-compound pricing |
| Full Review | Read Marek Review → | Read Limitless Review → |
This is one of the most evenly matched comparisons on our site. Both clinics offer BPC-157, PT-141, Sermorelin, and GHK-Cu. But Marek Health extends further with CJC-1295, Ipamorelin (GHRH/GHRP combo protocols), Thymosin Beta-4, and their Marek Diagnostics lab infrastructure — giving users a full ecosystem of advanced peptide protocols with physician-monitored biomarker tracking.
Limitless Alt Med answers with published pricing, free consultations, oral TRT, and a 95% no-bloodwork access rate for most compounds. For patients who want to explore peptides without paying $250 upfront for a consultation or $595 for a lab panel, Limitless is the more accessible starting point.
BPC-157, CJC-1295, Ipamorelin, PT-141, TB-4, GHK-Cu, full TRT panel. Marek Diagnostics labs. Physician-led. Founded by Derek (MPMD).
BPC-157 $325, PT-141 $184, Sermorelin $194, GHK-Cu, NAD+ $180/vial, TRT $115–$170/mo. Free consults. Published pricing. 95% no labs required.
Marek Health is the right choice for patients who want the deepest peptide protocols available in telehealth — CJC-1295/Ipamorelin combos, TB-4, and Marek Diagnostics labs are difficult to find elsewhere. The higher upfront cost is justified by the infrastructure.
Limitless Alt Med wins for patients who want published pricing, free consultations, and accessible entry to BPC-157 and PT-141 without large upfront fees or mandatory bloodwork. For anyone curious about peptides but hesitant about committing to a premium clinic, Limitless is the better starting point.
Yes — both Marek Health and Limitless Alt Med offer BPC-157 injectable. Limitless publishes a price of $325. Marek Health's pricing is variable within their pay-per-service model.
Yes — Limitless Alt Med offers free consultations. Marek Health charges $250 for the initial consultation before starting any protocol. For patients exploring options, Limitless removes this barrier.
Yes. Marek Diagnostics is Quest-partnered with 2,000+ draw locations and 80+ biomarker panels around $595 for comprehensive work. Limitless Alt Med recommends TRT monitoring at approximately $150/year (4x annually) but does not operate a dedicated diagnostics service.